Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2009-03-05 18:00 |
Publication des droits de vote février 2009
|
French | 6.6 KB | ||
| 2009-03-03 17:40 |
VIVALIS AND FORT DODGE ANIMAL HEALTH SIGN A COMMERCIAL
|
English | 50.3 KB | ||
| 2009-03-03 17:40 |
VIVALIS ET FORT DODGE ANIMAL HEALTH SIGNENT UNE LICENCE COMMERCIALE POUR UTILIS…
|
French | 50.9 KB | ||
| 2009-02-17 17:40 |
VIVALIS ET BOEHRINGER INGELHEIM ANIMAL HEALTH SIGNENT UNE LICENCE DE RECHERCHE
|
French | 71.8 KB | ||
| 2009-02-17 17:40 |
VIVALIS AND BOEHRINGER INGELHEIM ANIMAL HEALTH
|
English | 91.4 KB | ||
| 2009-02-09 17:40 |
VIVALIS ACHIEVES SIGNIFICANT MILESTONES IN THE DEVELOPMENT OF HUMAN FLU VACCINES
|
English | 86.3 KB | ||
| 2009-02-09 17:40 |
VIVALIS FRANCHIT DES ETAPES MAJEURES DANS LE DEVELOPPEMENT DU VACCIN HUMAIN CON…
|
French | 95.2 KB | ||
| 2009-02-06 17:45 |
DECLARATION ACTION ET DROIT DE VOTE
|
French | 6.5 KB | ||
| 2009-02-03 17:40 |
VIVALIS & NOVAVAX SIGN A RESEARCH LICENSE AGREEMENT
|
English | 116.9 KB | ||
| 2009-02-03 17:40 |
VIVALIS & NOVAVAX SIGNENT UNE LICENCE DE RECHERCHE
|
French | 121.1 KB | ||
| 2009-01-27 17:40 |
Vivalis multiplies annual revenue by 5 and increases cash
|
English | 107.6 KB | ||
| 2009-01-27 17:40 |
Vivalis multiplie son chiffre d'affaires par 5 en 2008 et augmente sa trésorerie
|
French | 110.6 KB | ||
| 2009-01-21 17:40 |
VIVALIS AND INNATE PHARMA SIGN A COLLABORATION AND COMMERCIAL LICENSE AGREEMENT…
|
English | 124.6 KB | ||
| 2009-01-21 17:40 |
VIVALIS ET INNATE PHARMA SIGNENT UN ACCORD DE COLLABORATION ET DE LICENCE COMME…
|
French | 125.1 KB | ||
| 2009-01-13 17:40 |
VIVALIS: PURSUIT OF ROBUST COMMERCIAL EXPANSION
|
English | 67.6 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
